5-Hydroxy-4-oxo-4H-pyran-2-carboxylic acid - CAS 499-78-5
Catalog: |
BB026874 |
Product Name: |
5-Hydroxy-4-oxo-4H-pyran-2-carboxylic acid |
CAS: |
499-78-5 |
Synonyms: |
5-hydroxy-4-oxopyran-2-carboxylic acid |
IUPAC Name: | 5-hydroxy-4-oxopyran-2-carboxylic acid |
Description: | Used in the regenerative anti-inflammatory composition. |
Molecular Weight: | 156.09 |
Molecular Formula: | C6H4O5 |
Canonical SMILES: | C1=C(OC=C(C1=O)O)C(=O)O |
InChI: | InChI=1S/C6H4O5/c7-3-1-5(6(9)10)11-2-4(3)8/h1-2,8H,(H,9,10) |
InChI Key: | UUUICOMMFFTCHS-UHFFFAOYSA-N |
Boiling Point: | 420.7 °C at 760 mmHg |
Melting Point: | 284-294 °C |
Purity: | 98 % |
Density: | 1.819 g/cm3 |
Appearance: | White to tan solid |
MDL: | MFCD03085981 |
LogP: | 0.04360 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P264, P270, P301+P317, P330, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
RU-2715001-C2 | Thickener of aqueous solution of acid and / or salt, method of thickening aqueous solution of acid and / or salt and method of oil production using said thickener, set of components for thickening of aqueous solution of acid and / or salt and composition for implementation of acid hydraulic fracturing of formation, including said thickener | 20190729 |
WO-2019200314-A2 | Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof | 20180413 |
AU-2019252933-A1 | Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof | 20180413 |
EP-3773900-A2 | Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof | 20180413 |
KR-20210020876-A | Hinokitiol analogue, preparation method thereof and pharmaceutical composition | 20180413 |
PMID | Publication Date | Title | Journal |
22268037 | 20110201 | Neuroprotector effect of comenic acid against cytotoxic action of glutamate in vitro in cultured neurons of lead-poisoned rat pups | Bulletin of experimental biology and medicine |
20077437 | 20100801 | p-coumaric acid not only inhibits human tyrosinase activity in vitro but also melanogenesis in cells exposed to UVB | Phytotherapy research : PTR |
Complexity: | 273 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 156.00587322 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 5 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 156.00587322 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 83.8 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.3 |
-
Catalog: BB023016
2-(4-Bromophenoxy)tetrahydro-2H-pyran
Detail
-
Catalog: BB054418
4-(Aminomethyl)-N,N-dimethyltetrahydro-2H-pyran-4-amine dihydrochloride
Detail
-
Catalog: BB009582
1-(4-Tetrahydropyranyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole Hydrochloride
Detail
-
Catalog: BB018982
4-Iodotetrahydro-2H-pyran
Detail
-
Catalog: BB077473
4-Chloro-4-methyloxane
Detail
-
Catalog: BB035059
Quercetin-3-gentiobioside
Detail
-
Catalog: BB078726
1-Methyl-3-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Detail
-
Catalog: BB078166
2-Phenyltetrahydro-2H-pyran-4-ol
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Pyrans
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS